The discovery of new Bcl-2 protein鈥損rotein interaction antagonists is described. We replaced the northern fragment of ABT737 (蟺鈥撓€ stacking interactions) with structurally simplified hydrophobic cage structures with much reduced conformational flexibility and rotational freedom. The binding mode of the compounds was elucidated by X-ray crystallography, and the compounds showed excellent oral bioavailability and clearance in rat PK studies.